Display options
Share it on

J Mov Disord. 2015 Jan;8(1):14-20. doi: 10.14802/jmd.14038. Epub 2015 Jan 13.

Current Status of Huntington's Disease in Korea: A Nationwide Survey and National Registry Analysis.

Journal of movement disorders

Hyun Sook Kim, Chul Hyoung Lyoo, Phil Hyu Lee, Sang Jin Kim, Mee Young Park, Hyeo-Il Ma, Jae Hyeok Lee, Sook Kun Song, Jong Sam Baik, Jin Ho Kim, Myung Sik Lee

Affiliations

  1. Department of Neurology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
  2. Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  3. Department of Neurology and Brain Research Institute, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.
  4. Department of Neurology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  5. Department of Neurology, Yeungnam University Medical Center, Daegu, Korea.
  6. Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea.
  7. Department of Neurology, Pusan National University Yangsan Hospital, Yangsan, Korea.
  8. Department of Neurology, Jeju National University Hospital, Jeju, Korea.
  9. Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.
  10. Department of Neurology, Chosun University School of Medicine, Gwangju, Korea.

PMID: 25614781 PMCID: PMC4298714 DOI: 10.14802/jmd.14038

Abstract

OBJECTIVE: Huntington's disease (HD) is a rare neurological disorder, and its current status in Korea is not well investigated. This study aims to determine the prevalence and incidence of HD and to investigate the clinical features of HD patients in Korea.

METHODS: We estimated the crude prevalence and annual incidence of HD based on the databases of the Rare Diseases Registry (RDR) and the National Health Insurance (NHI). The clinical data of genetically confirmed HD patients was collected from 10 referral hospitals and analyzed.

RESULTS: The mean calculated annual incidence was 0.06 cases per 100,000 persons, and the mean calculated prevalence was 0.38 based on the NHI database. The estimated crude prevalence based on the RDR was 0.41. Of the sixty-eight HD patients recruited, the mean age of onset was 44.16 ± 14.08 years and chorea was most frequently reported as the initial symptom and chief complaint. The mean CAG repeat number of the expanded allele was 44.7 ± 4.8 and correlated inversely with the age of onset (p < 0.001). About two-thirds of the patients have a positive family history, and HD patients without positive family history showed a delay in onset of initial symptoms, a prolonged interval between initial symptom onset and genetic diagnosis and a delay in the age of genetic diagnosis.

CONCLUSIONS: To the best of our knowledge, this is the first study to estimate the prevalence and incidence of HD in Korea and the largest HD series in the Asian population. Our analyses might be useful for further studies and large-scale investigations in HD patients.

Keywords: Database; Huntington’s disease; Incidence; Phenotype; Prevalence

References

  1. J Neurol Sci. 2010 Nov 15;298(1-2):57-60 - PubMed
  2. Mov Disord. 2014 Sep 15;29(11):1359-65 - PubMed
  3. J Clin Neurol. 2013 Jan;9(1):21-5 - PubMed
  4. J Med Genet. 1995 May;32(5):399-400 - PubMed
  5. Lancet Neurol. 2011 Jan;10 (1):83-98 - PubMed
  6. Mov Disord. 2012 Aug;27(9):1083-91 - PubMed
  7. J Huntingtons Dis. 2013;2(1):83-7 - PubMed
  8. Hum Mol Genet. 1993 Oct;2(10):1535-40 - PubMed
  9. Clin Genet. 2004 Apr;65(4):267-77 - PubMed
  10. Neurology. 2013 Sep 17;81(12):1099-100 - PubMed
  11. Lancet Neurol. 2011 Jan;10 (1):31-42 - PubMed
  12. Neuroepidemiology. 2010;35(4):250-4 - PubMed
  13. Am J Hum Genet. 1997 May;60(5):1202-10 - PubMed
  14. Clin Genet. 2010 Oct;78(4):381-7 - PubMed
  15. Neuroepidemiology. 1996;15(3):126-31 - PubMed
  16. J Neurol Neurosurg Psychiatry. 2013 Oct;84(10 ):1156-60 - PubMed
  17. J Med Genet. 1995 Sep;32(9):701-5 - PubMed
  18. Eur J Hum Genet. 2011 May;19(5):561-6 - PubMed
  19. Nat Genet. 1994 Aug;7(4):525-30 - PubMed
  20. Clin Exp Neurol. 1994;31:43-51 - PubMed
  21. Cell. 1993 Mar 26;72(6):971-83 - PubMed
  22. Arch Med Res. 2008 Jan;39(1):131-3 - PubMed
  23. J Clin Neurol. 2014 Jan;10(1):32-6 - PubMed
  24. PLoS Curr. 2011 Jul 29;3:RRN1258 - PubMed
  25. Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):314-20 - PubMed
  26. Hum Mol Genet. 1994 Dec;3(12):2103-14 - PubMed
  27. Am J Med Genet A. 2009 Jul;149A(7):1375-81 - PubMed
  28. Neurology. 2009 Oct 20;73(16):1280-5 - PubMed
  29. Clin Genet. 2001 Sep;60(3):198-205 - PubMed
  30. Epidemiology. 1999 Nov;10(6):706-10 - PubMed
  31. Mov Disord. 2014 Sep 15;29(11):1342-50 - PubMed
  32. Lancet Neurol. 2010 Aug;9(8):751 - PubMed

Publication Types